A majority of Australian pharmacists would support the use of a cardiovascular polypill as one solution to poor medication compliance, a new study has revealed.
Researchers from the George Institute for Global Health at the University of Sydney found that 73 per cent of pharmacists they surveyed agreed that a polypill would improve compliance, while 79 per cent said its use would reduce patient medication costs.
The pharmacists had said that polypharmacy – the use of multiple concurrent medications – was the major barrier to cardiovascular medication compliance. Other barriers they identified included patient disinterest, time constraints and cost.
Detailed questionnaires were completed by 72 NSW pharmacists. In-depth interviews were conducted with 10 of the respondents.
These revealed similar findings to the questionnaires, especially...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.